Quest Diagnostics Inc (DGX) stock
DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/3010% above fair value
$259.60−0.05 (-0.02%)
Close on Nov 13, 2026Market cap $28.56BP/E 25.9Yield –
Quest Diagnostics gross margin
Gross margin is gross profit as a percentage of revenue.
Quest Diagnostics's gross margin for the twelve months ending Sep 30, 2026 was 33.1%. For fiscal 2025 it was 33.2%, against 32.9% the year before. The highest annual figure on record is 42.0% in fiscal 2009.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 33.2% | +0.4 |
| FY2024 | Dec 31, 2024 | 32.9% | −0.1 |
| FY2023 | Dec 31, 2023 | 33.0% | −1.7 |
| FY2022 | Dec 31, 2022 | 34.7% | −4.3 |
| FY2021 | Dec 31, 2021 | 39.0% | +0.5 |
| FY2020 | Dec 31, 2020 | 38.5% | +3.7 |
| FY2019 | Dec 31, 2019 | 34.8% | +0.2 |
| FY2018 | Dec 31, 2018 | 34.6% | −1.7 |
| FY2017 | Dec 31, 2017 | 36.2% | −3.9 |
| FY2016 | Dec 31, 2016 | 40.2% | +2.3 |
| FY2015 | Dec 31, 2015 | 37.8% | +0.2 |
| FY2014 | Dec 31, 2014 | 37.6% | −1.8 |
| FY2013 | Dec 31, 2013 | 39.5% | −1.4 |
| FY2012 | Dec 31, 2012 | 40.9% | −0.1 |
| FY2011 | Dec 31, 2011 | 41.0% | −1.1 |
| FY2010 | Dec 31, 2010 | 42.0% | −0.0 |
| FY2009 | Dec 31, 2009 | 42.0% | +0.7 |
| FY2008 | Dec 31, 2008 | 41.3% | +0.5 |
| FY2007 | Dec 31, 2007 | 40.8% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 33.6% | −0.1 |
| Q2 FY2026 | Jun 30, 2026 | 33.7% | −0.4 |
| Q1 FY2026 | Mar 31, 2026 | 32.5% | −0.0 |
| Q4 FY2025 | Dec 31, 2025 | 32.4% | −0.3 |
| Q3 FY2025 | Sep 30, 2025 | 33.7% | +1.1 |
| Q2 FY2025 | Jun 30, 2025 | 34.2% | +0.6 |
| Q1 FY2025 | Mar 31, 2025 | 32.5% | −0.0 |
| Q4 FY2024 | Dec 31, 2024 | 32.7% | +0.6 |
| Q3 FY2024 | Sep 30, 2024 | 32.6% | −0.3 |
| Q2 FY2024 | Jun 30, 2024 | 33.5% | −0.3 |
| Q1 FY2024 | Mar 31, 2024 | 32.6% | −0.5 |
| Q4 FY2023 | Dec 31, 2023 | 32.2% | −0.3 |
| Q3 FY2023 | Sep 30, 2023 | 32.9% | −2.1 |
| Q2 FY2023 | Jun 30, 2023 | 33.9% | −0.5 |
| Q1 FY2023 | Mar 31, 2023 | 33.1% | −3.9 |
| Q4 FY2022 | Dec 31, 2022 | 32.5% | −4.9 |
| Q3 FY2022 | Sep 30, 2022 | 34.9% | −4.9 |
| Q2 FY2022 | Jun 30, 2022 | 34.3% | −4.3 |
| Q1 FY2022 | Mar 31, 2022 | 37.0% | −3.3 |
| Q4 FY2021 | Dec 31, 2021 | 37.4% | −4.9 |
| Q3 FY2021 | Sep 30, 2021 | 39.8% | −3.5 |
| Q2 FY2021 | Jun 30, 2021 | 38.6% | +5.5 |
| Q1 FY2021 | Mar 31, 2021 | 40.2% | +9.9 |
| Q4 FY2020 | Dec 31, 2020 | 42.3% | +7.9 |
| Q3 FY2020 | Sep 30, 2020 | 43.3% | +7.9 |
| Q2 FY2020 | Jun 30, 2020 | 33.2% | −2.1 |
| Q1 FY2020 | Mar 31, 2020 | 30.3% | −3.9 |
| Q4 FY2019 | Dec 31, 2019 | 34.4% | +1.5 |
| Q3 FY2019 | Sep 30, 2019 | 35.4% | +0.1 |
| Q2 FY2019 | Jun 30, 2019 | 35.2% | +0.0 |
| Q1 FY2019 | Mar 31, 2019 | 34.2% | −0.7 |
| Q4 FY2018 | Dec 31, 2018 | 32.8% | −3.1 |
| Q3 FY2018 | Sep 30, 2018 | 35.3% | −0.6 |
| Q2 FY2018 | Jun 30, 2018 | 35.2% | −2.0 |
| Q1 FY2018 | Mar 31, 2018 | 34.9% | −1.0 |
| Q4 FY2017 | Dec 31, 2017 | 36.0% | −1.7 |
| Q3 FY2017 | Sep 30, 2017 | 35.9% | – |
| Q2 FY2017 | Jun 30, 2017 | 37.2% | – |
| Q1 FY2017 | Mar 31, 2017 | 35.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 37.7% | – |
See a number that looks wrong?